Endovascular Repair for Ascending Aortic Graft Side Branch Pseudoaneurysm: A Report of Two Cases.
Ascending aortic replacement
Graft side branch
Pseudoaneurysm
Redo surgery
Thoracic endovascular aortic repair
Journal
EJVES vascular forum
ISSN: 2666-688X
Titre abrégé: EJVES Vasc Forum
Pays: England
ID NLM: 101766732
Informations de publication
Date de publication:
2022
2022
Historique:
received:
27
09
2021
revised:
13
03
2022
accepted:
28
03
2022
entrez:
6
5
2022
pubmed:
7
5
2022
medline:
7
5
2022
Statut:
epublish
Résumé
A pseudoaneurysm arising from the side branch of the prosthesis, following ascending aortic replacement, is extremely rare. Re-intervention usually involves open surgery, replacement of the ascending aorta, or ligation of the side branch. Redo surgery with an additional sternotomy carries the risk of cardiac and vascular injuries, and endovascular treatment can reduce such adverse events. This study describes the successful thoracic endovascular aortic repair (TEVAR) of two cases of pseudoaneurysms arising from the side branch after ascending aortic replacement. Case 1 involved a 79 year old man who underwent ascending aortic replacement and omentopexy for a ruptured tuberculous aortic aneurysm 13 years ago. The pseudoaneurysm was mushroom shaped with a 30 mm protrusion. Case 2 involved an 83 year old man who underwent ascending aortic replacement for Stanford type A acute aortic dissection 11 years ago. The pseudoaneurysm was rod shaped with a 27 mm protrusion. In both cases, the pseudoaneurysm arising from the side branch was not noted on computed tomography (CT) until one year earlier and was first identified at a routine follow up examination. The pseudoaneurysms required surgical repair because of the risk of rupture; however, TEVAR was selected considering the risks of redo surgery and the patients' ages. It was performed via a femoral artery approach without adverse events using a commercially available thoracic aortic device. Post-operative CT scan showed complete exclusion of the pseudoaneurysm. Although TEVAR is usually not indicated for ascending aortic pathologies, if there is an anatomical indication and a compatible stent graft, TEVAR for the ascending aorta should be the first choice in patients who are inoperable, at high risk and undergoing redo surgery.
Identifiants
pubmed: 35515008
doi: 10.1016/j.ejvsvf.2022.03.009
pii: S2666-688X(22)00032-6
pmc: PMC9062449
doi:
Types de publication
Case Reports
Langues
eng
Pagination
48-51Informations de copyright
© 2022 The Author(s).
Références
Ann Vasc Surg. 2020 Apr;64:412.e1-412.e5
pubmed: 31669481
Asian Cardiovasc Thorac Ann. 2020 Jul;28(6):330-332
pubmed: 32551841
Ann Cardiothorac Surg. 2016 Jul;5(4):389-96
pubmed: 27563553
J Thorac Cardiovasc Surg. 2015 Jan;149(1):144-51
pubmed: 25312226
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1381-1389
pubmed: 29395197
J Endovasc Ther. 2000 Dec;7(6):506-12
pubmed: 11194823
Cardiovasc Intervent Radiol. 2021 Sep;44(9):1448-1455
pubmed: 34180002
Ann Thorac Surg. 2020 Mar;109(3):678-685
pubmed: 31472140
J Thorac Cardiovasc Surg. 2016 Jun;151(6):1606-14
pubmed: 26872446
J Vasc Surg. 2017 Nov;66(5):1587-1601
pubmed: 28830707